Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_assertion description "[Previous studies demonstrated that metformin is a potent inhibitor of ErbB2-overexpressing breast cancer cells; metformin treatment extends the life span and impedes mammary tumor development in ErbB2 transgenic mice in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_assertion evidence source_evidence_literature NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_assertion SIO_000772 24322659 NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_assertion wasDerivedFrom befree-2016 NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_assertion wasGeneratedBy ECO_0000203 NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1135256.RAcjba5hWiwxwHc0Rc86gW3newus-hrT7npTe_c7Z0nyw130_provenance.